Genedx Holdings (WGS): CEO sold ~$271K
Katherine Stueland, CEO at Genedx Holdings, sold ~$271K of Genedx Holdings shares.
- ~$271K
- Approx. value · 3,175 sh @ $85.44
- 34K
- Holds after · shares reported
- Traded
- Apr 9, 2025
- Filed
- Apr 10, 2025
What stands out in this filing
- The sale was 8.6% of the shares this insider held before it; the filing reports 33,939 shares afterwards.
- 3,175 shares at an average of $85.44 each, as reported on the form.
- Footnote references a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 3, 2025InsiderCFO sold ~$27K of WGS shares in the open market
- Mar 10, 2025Insider · 2 peopleInsiders: 2 sales (~$346K)
- Mar 13, 2025Insider · 2 peopleInsiders: 2 sales (~$133K)
- Mar 17, 2025Insider · 2 peopleInsiders: 2 sales (~$1.4M)
- Mar 26, 2025Insider · 2 peopleInsiders: 4 sales (~$5.3M)
- Apr 9, 2025 · this disclosureInsiderCEO sold ~$271K of WGS shares in the open market
What came next
- Apr 9, 2025Insider · 2 peopleInsiders: 24 sales (~$5.2M)
- Apr 29, 2025Insider · 2 peopleInsiders: 2 sales (~$287K)
- May 8, 2025Insider · 1 personInsiders: 3 purchases (~$5.6M)
- May 14, 2025Insider · 1 personInsiders: 2 purchases (~$3.0M)
- Jun 2, 2025InsiderCFO sold ~$26K of WGS shares in the open market
- Jun 9, 2025Insider · 2 peopleInsiders: 2 sales (~$356K)
- Jun 16, 2025Insider · 2 peopleInsiders: 2 sales (~$922K)
- Jul 1, 2025Insider · 2 peopleInsiders: 5 sales (~$1.0M)
- Jul 9, 2025Insider · 2 peopleInsiders: 2 sales (~$790K)
- Jul 29, 2025Insider · 2 peopleInsiders: 2 sales (~$268K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Genedx Holdings
For Genedx Holdings, OQRO holds 3 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WGS page.
Other recent filings by Katherine Stueland, Chief Executive Officer
- SEC Form 4 at Genedx Holdings (WGS)Sep 18, 2025
- SEC Form 4 at Genedx Holdings (WGS)Sep 11, 2025
- SEC Form 4 at Genedx Holdings (WGS)Sep 11, 2025
- SEC Form 4 at Genedx Holdings (WGS)Jul 31, 2025
- SEC Form 4 at Genedx Holdings (WGS)Jul 11, 2025
The full history of Katherine Stueland, Chief Executive Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Genedx Holdings (WGS) insider traded, and how much?
Katherine Stueland, CEO at Genedx Holdings, sold ~$271K of Genedx Holdings shares. 3,175 shares at $85.44.
When did it happen, and when was it made public?
Traded: Apr 9, 2025. Filed: Apr 10, 2025. That is 1 day between the two dates.
What stands out in this filing?
The sale was 8.6% of the shares this insider held before it; the filing reports 33,939 shares afterwards. 3,175 shares at an average of $85.44 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Genedx Holdings recently?
For Genedx Holdings, OQRO holds 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the WGS page.
Does this mean WGS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Genedx Holdings
- SEC Schedule 13GNov 17, 2026
- SEC Form 13F-HRNov 13, 2026
- SEC Schedule 13GNov 6, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its WGS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
